OBJECTIVES: Transplantation of endothelial progenitor cells (EPCs) is a promising approach for revascularization of tissue. We have used a natural and biocompatible biopolymer, fibrin, to induce cell population growth, differentiation and functional activity of EPCs. MATERIALS AND METHODS: Peripheral blood mononuclear cells were cultured for 1 week to obtain early EPCs. Fibrin was characterized for stiffness and capability to sustain cell population expansion at different fibrinogen-thrombin ratios. Viability, differentiation and angiogenic properties of EPCs were evaluated and compared to those of EPCs grown on fibronectin. RESULTS: Fibrin had a nanometric fibrous structure forming a porous network. Fibrinogen concentration significantly influenced fibrin stiffness and cell growth: 9 mg/ml fibrinogen and 25 U/ml thrombin was the best ratio for enhanced cell viability. Moreover, cell viability was significantly higher on fibrin compared to being on fibronectin. Even though no significant difference was observed in expression of endothelial markers, culture on fibrin elicited marked induction of stem cell markers OCT 3/4 and NANOG. In vitro angiogenesis assay on Matrigel showed that EPCs grown on fibrin retain angiogenetic capability as EPCs grown on fibronectin, but significantly better release of cytokines involved in cell recruitment was produced by EPC grown on fibrin. CONCLUSION: Fibrin is a suitable matrix for EPC growth, differentiation and angiogenesis capability, suggesting that fibrin gel may be very useful for regenerative medicine.
OBJECTIVES: Transplantation of endothelial progenitor cells (EPCs) is a promising approach for revascularization of tissue. We have used a natural and biocompatible biopolymer, fibrin, to induce cell population growth, differentiation and functional activity of EPCs. MATERIALS AND METHODS: Peripheral blood mononuclear cells were cultured for 1 week to obtain early EPCs. Fibrin was characterized for stiffness and capability to sustain cell population expansion at different fibrinogen-thrombin ratios. Viability, differentiation and angiogenic properties of EPCs were evaluated and compared to those of EPCs grown on fibronectin. RESULTS: Fibrin had a nanometric fibrous structure forming a porous network. Fibrinogen concentration significantly influenced fibrin stiffness and cell growth: 9 mg/ml fibrinogen and 25 U/ml thrombin was the best ratio for enhanced cell viability. Moreover, cell viability was significantly higher on fibrin compared to being on fibronectin. Even though no significant difference was observed in expression of endothelial markers, culture on fibrin elicited marked induction of stem cell markers OCT 3/4 and NANOG. In vitro angiogenesis assay on Matrigel showed that EPCs grown on fibrin retain angiogenetic capability as EPCs grown on fibronectin, but significantly better release of cytokines involved in cell recruitment was produced by EPC grown on fibrin. CONCLUSION: Fibrin is a suitable matrix for EPC growth, differentiation and angiogenesis capability, suggesting that fibrin gel may be very useful for regenerative medicine.
Authors: W Liu; L M Jawerth; E A Sparks; M R Falvo; R R Hantgan; R Superfine; S T Lord; M Guthold Journal: Science Date: 2006-08-04 Impact factor: 47.728
Authors: Carmen Urbich; Alexandra Aicher; Christopher Heeschen; Elisabeth Dernbach; Wolf K Hofmann; Andreas M Zeiher; Stefanie Dimmeler Journal: J Mol Cell Cardiol Date: 2005-09-29 Impact factor: 5.000
Authors: T Asahara; T Murohara; A Sullivan; M Silver; R van der Zee; T Li; B Witzenbichler; G Schatteman; J M Isner Journal: Science Date: 1997-02-14 Impact factor: 47.728
Authors: Nelli Baal; Kerstin Reisinger; Henning Jahr; Rainer M Bohle; Olin Liang; Karsten Münstedt; C V Rao; Klaus T Preissner; Marek T Zygmunt Journal: Thromb Haemost Date: 2004-10 Impact factor: 5.249
Authors: Rajiv Gulati; Dragan Jevremovic; Timothy E Peterson; Suvro Chatterjee; Vijay Shah; Richard G Vile; Robert D Simari Journal: Circ Res Date: 2003-11-06 Impact factor: 17.367
Authors: Rose L Spear; Brajith Srigengan; Suresh Neelakantan; Wolfram Bosbach; Roger A Brooks; Athina E Markaki Journal: Tissue Eng Part A Date: 2014-10-03 Impact factor: 3.845
Authors: Kaitlin C Murphy; Marissa L Hughbanks; Bernard Y K Binder; Caroline B Vissers; J Kent Leach Journal: Ann Biomed Eng Date: 2014-12-20 Impact factor: 3.934
Authors: Rizwan Ali; Sarah Huwaizi; Alshaimaa Alhallaj; Arwa Al Subait; Tlili Barhoumi; Hajar Al Zahrani; Abdullah Al Anazi; Abdul Latif Khan; Mohamed Boudjelal Journal: Front Mol Biosci Date: 2021-12-24